HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AI-Backed Personalization Could ‘Transform’ Consumer Product Advertising, Sales By 2030

Executive Summary

“If the previous decade was about the new digital, the current decade will require brands to undergo dynamic transformation,” said creative media consultant Kate Scott-Dawkins at NAD conference.

You may also be interested in...



HBW Insight’s Key Takeaways From 2021: #3 Keep Your Eye On AI

The future of digital health will be shaped more than anything else by the rise of artificial intelligence. From body enhancing bio-wearables to camera-based skin diagnostics, the consumer health industry continued to explore the possibilities presented by AI in 2021. However, there are many regulatory and ethical hurdles industry must overcome as we move into 2022 and beyond.

Boiron Moves Into Personalized Beauty As Sales Continue To Slide

France's Boiron has acquired cosmetics player ABBI, which uses artificial intelligence to offer consumers personalized beauty products. The move comes as Boiron reported 2021 sales down double-digits as homeopathy sales in its home market continue to decline.

More Big Beauty Companies Partner With Digital Tech To Guide Consumer Journey

Beiersdorf AG and dermanostic will connect German consumers with physicians for mobile app-based dermatological diagnoses and product recommendations. Meanwhile, Shiseido will be leveraging Revieve’s AI Makeup Advisor to “take control over the multi-touchpoint customer journey.”

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS151812

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel